Aaron Edelheit: Crash Course on Cannabis Investing

Episode Summary

Executive Summary: The episode argues that cannabis may be at a political inflection point, with Chuck Schumer’s path to reelection potentially clearing the way for incremental reform like SAFE Banking. The guest believes federal reform, state legalization, and growing consumer/brand dynamics could unlock major upside in beaten-down cannabis equities, while stressing the sector remains highly inefficient, illiquid, and risky.

Main Topics: Political catalyst for cannabis reform (Priority: 5/5): The discussion centers on the idea that Chuck Schumer’s lack of a serious progressive primary challenger may reduce resistance to incremental cannabis legislation, especially SAFE Banking, creating a near-term policy window. SAFE Banking and market access (Priority: 5/5): SAFE Banking is framed as the most important incremental reform because it would reduce cash reliance, improve banking access, lower financing costs, expand institutional participation, and potentially enable uplisting to major exchanges. Cannabis brand power and consumer behavior (Priority: 4/5): The guest argues cannabis will develop durable brands similar to alcohol or CPG, citing product consistency, repeat purchases, and examples like Cookies and Kiva as evidence that brand loyalty can emerge. Operational complexity and barriers to entry (Priority: 5/5): Cannabis is presented as unusually hard to produce and scale due to indoor cultivation, regulatory fragmentation, vertical integration rules, and state-by-state licensing constraints, which help entrench leading operators. Investment framework for cannabis equities (Priority: 4/5): The guest explains a long-term, value-oriented approach focused on ethical management, clear strategy, low valuation, and balance-sheet discipline rather than short-term price prediction. Glasshouse and low-cost production thesis (Priority: 4/5): Glasshouse is highlighted as a differentiated operator using greenhouse production in Southern California to achieve much lower costs than indoor growers, potentially benefiting if interstate commerce opens. Broader social and capital market impacts (Priority: 3/5): The episode connects cannabis reform to social equity, public safety, reduced opioid use, tax revenue growth, and the need for capital access for minority-owned and smaller operators.

Key Arguments: SAFE Banking could have broad bipartisan support and is the most realistic near-term reform, unlike comprehensive legalization, which is blocked by Senate filibuster dynamics. Chuck Schumer’s political incentives may have changed because he no longer faces a serious progressive primary threat, reducing his need to hold out for a maximalist cannabis bill. Cannabis companies are structurally constrained by federal illegality, which excludes most institutional capital and keeps valuations depressed despite strong growth. Branding will matter in cannabis because consumers seek consistency and repeatable experiences, just as they do in alcohol, coffee, or other CPG categories. The biggest operational challenge is scaling high-quality cannabis consistently; this favors operators with strong cultivation teams and disciplined processes. State-by-state licensing and vertical integration rules create scarce, valuable licenses and make expansion highly complex and capital intensive. Long-term upside exists because legal cannabis demand is likely to expand materially as more states adopt adult use and the market matures. The market is inefficient enough that investors can still find mispriced assets by doing basic due diligence on licenses, real estate, and private-market comparables. Interstate commerce would be a major risk to some MSOs but a major opportunity for low-cost producers like Glasshouse. The right way to invest in cannabis is with patient capital that can withstand large drawdowns and long timing uncertainty.

Data Points: SAFE Banking in House: Passed 6 times - Guest says the House has passed SAFE Banking repeatedly, but it has never received a Senate hearing. Estimated Senate support for SAFE Banking: More than 60 senators - Guest believes SAFE Banking has sufficient bipartisan support to clear the Senate if brought to a vote. Cannabis institutional participation: 95%-98% excluded - Guest estimates nearly all institutional investors are not involved due to custody, compliance, and legality issues. Cannabis industry taxation: 280e - Mentioned as the tax code provision preventing normal business deductions for cannabis operators. Cannabis company bank accounts: 140 bank accounts - Example cited to illustrate the operational complexity of handling multi-state cash and banking needs. Private company borrowing costs: 3% per month - Guest cites some private cannabis companies paying extremely high monthly interest costs. Largest greenhouse scale: 5.5 million square feet - Glasshouse’s greenhouse in Southern California is described as the largest in the world. Energy savings from greenhouse model: 95% less energy - Guest says Glasshouse’s greenhouse approach uses far less energy than indoor cultivation. Glasshouse production cost: $166 per pound - Stated as current production cost before reaching the target of $100 per pound. Glasshouse target production cost: $100 per pound - Guest says Glasshouse is headed toward this lower cost level. Typical MSO production cost: $700-$1,000 per pound - Used to contrast indoor MSO economics with Glasshouse’s greenhouse model. California legal dispensaries: 860 - Guest says California has far fewer dispensaries than a mature market should have. Expected California dispensaries: 4,000-5,000 - Guest estimates how many California should have based on Colorado-like dynamics. Florida medical cannabis patients: <700,000 - Used to argue Florida adult-use potential is much larger than current medical participation. Florida total population: ~22 million - Used to frame Florida’s addressable market expansion. Florida tourism: 130 million visitors in 2019 - Guest argues tourists are a major untapped source of cannabis demand in Florida adult use. New York adult-use timing: April 11 / April 20 / May 1 - Guest cites several possible dates for New York’s legalization rollout. Goodness Growth acquisition value: North of $400 million (estimated private value) - Guest argues the company was underpriced relative to private-market license value before acquisition. Goodness Growth / Minnesota license reference: One of 2 licensed companies - Guest says Minnesota effectively has only two licensed operators after mergers. New York license count: 10 licensed companies - Used to show scarcity value in limited-license states. New Jersey license count: 15 operators - Used to illustrate limited competition in the New Jersey market. Florida dispensary revenue potential: $40 million+ per dispensary - Example given for a Fort Lee, NJ dispensary near New York as legalization broadens. Glasshouse interstate-commerce upside: $12/share cash flow potential - Guest claims that under an interstate commerce model, a $5 stock could produce about $12 a year in cash flow eventually. Fund performance YTD: Down 5%-6% - Guest says his dedicated cannabis fund was down modestly while the MSOS ETF was down much more. MSOS ETF decline: Down 20% YTD; 64% below highs - Used to show sector-wide weakness and volatility. Social/medical legalization support: 70%-91% public support - Guest claims broad public support for legalization or at least medicinal access. Opioid overdose reduction: 20% drop - Guest says opening one cannabis dispensary can reduce opioid overdoses and deaths by 20%. Massachusetts indoor cannabis electricity: 10% of electric demand - Guest uses this to criticize the energy intensity of indoor cultivation. Illinois / Massachusetts share: 20%-30% of population uses cannabis in mature markets - Guest cites this as a benchmark for eventual state demand in adult-use markets.

Pivotal Quotes: "I think you have better than even odds. I think it's about 60-65% in the next 90 days." — Aaron: He is estimating the probability and timing of SAFE Banking or related compromise legislation. "The biggest problem in cannabis was growing high-quality cannabis at scale consistently." — Aaron: He identifies cultivation consistency as the central operational challenge and the basis for brand durability. "I'm not paying 20 times sales, 40 times sales. I'm paying single-digit multiples for companies growing double-digit percentages." — Aaron: He describes why he sees cannabis as a value opportunity rather than a growth-stock trade.

Implications: If reform advances, capital, banking, and exchange access could re-rate cannabis equities sharply. Winners are likely to be disciplined operators with scarce licenses, low-cost production, and strong governance; timing remains highly uncertain.